First Time Loading...

Bruker Corp
NASDAQ:BRKR

Watchlist Manager
Bruker Corp Logo
Bruker Corp
NASDAQ:BRKR
Watchlist
Price: 93.86 USD 1.58% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microsc... [ Read More ]

The intrinsic value of one BRKR stock under the Base Case scenario is 82.13 USD. Compared to the current market price of 93.86 USD, Bruker Corp is Overvalued by 12%.

Key Points:
BRKR Intrinsic Value
Base Case
82.13 USD
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bruker Corp

Backtest BRKR Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BRKR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Bruker's Strong 2023 Performance and FY24 Outlook
2023-Q4 Earnings Call

Bruker's Strong 2023 Performance and FY24 Outlook

In 2023, Bruker demonstrated robust financial strength, achieving a third consecutive year of double-digit organic revenue growth, with a 15.9% increase in Q4 and 14.5% for the full year, leading to overall revenue growth of 17.1% to $2.96 billion. Even with strategic investments and acquisitions, non-GAAP EPS grew solidly by 10.3%. The Bruker Cellular Analysis segment, recently restructured, is expected to lessen its EPS dilution from $0.10 to $0.02-$0.03 quarterly, moving towards profitability in FY26. For FY24, Bruker forecasts a promising 5-7% growth in both organic revenue and non-GAAP EPS.

Financials

Balance Sheet Decomposition
Bruker Corp

Current Assets 2.2B
Cash & Short-Term Investments 488.3m
Receivables 492m
Other Current Assets 1.2B
Non-Current Assets 2.1B
PP&E 691.4m
Intangibles 913.1m
Other Non-Current Assets 481.2m
Current Liabilities 1.2B
Accounts Payable 202.7m
Other Current Liabilities 999.4m
Non-Current Liabilities 1.7B
Long-Term Debt 1.2B
Other Non-Current Liabilities 510.3m
Efficiency

Earnings Waterfall
Bruker Corp

Revenue
3B USD
Cost of Revenue
-1.4B USD
Gross Profit
1.5B USD
Operating Expenses
-1B USD
Operating Income
486.7m USD
Other Expenses
-59.5m USD
Net Income
427.2m USD

Free Cash Flow Analysis
Bruker Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

BRKR Profitability Score
Profitability Due Diligence

Bruker Corp's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Exceptional ROE
ROE is Increasing
65/100
Profitability
Score

Bruker Corp's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

BRKR Solvency Score
Solvency Due Diligence

Bruker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
High Interest Coverage
Short-Term Solvency
Long-Term Solvency
64/100
Solvency
Score

Bruker Corp's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BRKR Price Targets Summary
Bruker Corp

Wall Street analysts forecast BRKR stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRKR is 86.8 USD with a low forecast of 66.66 USD and a high forecast of 107.1 USD.

Lowest
Price Target
66.66 USD
29% Downside
Average
Price Target
86.8 USD
8% Downside
Highest
Price Target
107.1 USD
14% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BRKR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BRKR Price
Bruker Corp

1M 1M
+9%
6M 6M
+50%
1Y 1Y
+23%
3Y 3Y
+48%
5Y 5Y
+148%
10Y 10Y
+330%
Annual Price Range
93.86
52w Low
54.91
52w High
94.27
Price Metrics
Average Annual Return 19.08%
Standard Deviation of Annual Returns 29.89%
Max Drawdown -41%
Shares Statistics
Market Capitalization 13.6B USD
Shares Outstanding 137 671 008
Percentage of Shares Shorted 5.45%

BRKR Return Decomposition
Main factors of price return

What is price return decomposition?

BRKR News

Other Videos

Company Profile

Bruker Corp Logo
Bruker Corp

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

13.6B USD

Dividend Yield

0.22%

Description

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 7,765 full-time employees. The company went IPO on 2000-08-04. The firm operates through four segments: Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Group and Bruker Energy & Supercon Technologies (BEST). The Bruker BioSpin Group segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The Bruker CALID Group segment designs, manufactures, and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions. The BSI NANO Group segment designs and manufactures advanced X-ray instruments; advanced fluorescence optical microscopy instruments; analytical tools for electron microscopes and X-ray metrology; and defect-detection equipment. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

Contact

MASSACHUSETTS
Billerica
40 Manning Rd
+19786633660.0
https://www.bruker.com/

IPO

2000-08-04

Employees

7 765

Officers

Chairman, CEO & President
Dr. Frank H. Laukien Ph.D.
Executive VP & CFO
Mr. Gerald N. Herman
Corporate Executive VP and President of Bruker Nano Group & Corporate
Dr. Mark R. Munch Ph.D.
President of Bruker CALID Group & Bruker Daltonics Division
Mr. Juergen Srega
President of Bruker BioSpin Group
Dr. Falko Busse Ph.D.
Senior Director of Investor Relations & Corporate Development
Mr. Justin Joseph Ward
Show More
General Counsel & Secretary
Mr. J. Brent Alldredge J.D.
Treasurer & Director of Investor Relations
Stacey Desrochers
President and CEO of Bruker Energy & Supercon Technologies, Inc.
Dr. Burkhard Prause Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one BRKR stock?

The intrinsic value of one BRKR stock under the Base Case scenario is 82.13 USD.

Is BRKR stock undervalued or overvalued?

Compared to the current market price of 93.86 USD, Bruker Corp is Overvalued by 12%.